Skip to content

Clinical trials

Phase 3 Neoplasms trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 3 Country / region: India Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20072
20085
20093
20102
20111
20122
20131
20151
20171
20191
20203
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated5
Active, not recruiting4
Enrolling by invitation2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Sanofi3
All India Institute of Medical Sciences2
Amgen2
AstraZeneca2
Eli Lilly and Company2
Tata Memorial Hospital2
Tolmar Inc.2
Acerta Pharma BV1
Banaras Hindu University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms31
Breast Neoplasms6
Neoplasm Metastasis4
Neoplasms by Site3
Brain Neoplasms2
Breast Diseases2
Carcinoma, Non-Small-Cell Lung2
Esophageal Neoplasms2
Glioblastoma2
Leukemia, B-Cell2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.